iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIria Grande

About this trial

The goal of this clinical trial is to assess the effectiveness of an original intervention 'Functional Recovery in Depression and Suicide Risk Prevention Based on Emotion Regulation and Values: A Group Program' (from the original Spanish version: Programa Grupal De Recuperación Funcional En Depresión Y Prevención De Riesgo Suicida Basado En Regulación Emocional Y Valores) in depressed patients who have recently attempted suicide by improving their psychosocial functioning and therefore enhancing their ability to perform activities of daily living. As secondary objectives, the effectiveness of the intervention will be evaluated by determining cognitive performance (particularly decision-making, inhibition, and attention), quality of life, clinical status, and their relationship with neuroimaging correlates. Main target neuroimaging areas include the orbitofrontal cortex and dorsal prefrontal cortex.

Eligibility criteria

Qualifiers

Age over 18 years old

Having attempted suicide

Provide written informed consent

No claustrophobia/metallic objects/implants

Disqualifiers

Intelligence quotient below 70 and impaired functioning

Any medical condition that could affect neuropsychological performance (such as neurological diseases) or a history of head trauma with loss of consciousness

Participation in any structured psychological intervention within the past 6 months

Patients who received electroconvulsive therapy within the past 6 months

Trial design

Treatments tested in this trial

  • 'Functional Recovery in Depression and Suicide Risk Prevention Based on Emotion Regulation and Values: A Group Program'

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Iria Grande

Lead sponsor

Hospital Clinic of Barcelona

Sponsor institution